IRIS
PONZONI, MAURILIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.228
EU - Europa 9.944
NA - Nord America 6.541
SA - Sud America 3.120
AF - Africa 234
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 3
Totale 30.093
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.220
RU - Federazione Russa 6.055
SG - Singapore 3.700
CN - Cina 3.033
BR - Brasile 2.542
HK - Hong Kong 1.461
SE - Svezia 1.181
VN - Vietnam 1.066
IT - Italia 733
FR - Francia 542
DE - Germania 416
GB - Regno Unito 252
AR - Argentina 237
FI - Finlandia 178
IN - India 173
MX - Messico 131
AT - Austria 123
CA - Canada 122
EC - Ecuador 111
BD - Bangladesh 105
IE - Irlanda 102
ID - Indonesia 99
JP - Giappone 98
IQ - Iraq 74
NL - Olanda 71
TR - Turchia 71
ZA - Sudafrica 71
ES - Italia 66
PL - Polonia 66
CO - Colombia 59
PY - Paraguay 51
MA - Marocco 44
CL - Cile 38
PK - Pakistan 36
SA - Arabia Saudita 36
VE - Venezuela 36
UA - Ucraina 33
UZ - Uzbekistan 27
KE - Kenya 26
TN - Tunisia 25
PE - Perù 22
EG - Egitto 21
AE - Emirati Arabi Uniti 19
AU - Australia 19
IR - Iran 19
KR - Corea 19
PT - Portogallo 19
PH - Filippine 17
JO - Giordania 15
DZ - Algeria 14
LT - Lituania 14
MY - Malesia 14
BE - Belgio 13
IL - Israele 13
OM - Oman 13
UY - Uruguay 13
LB - Libano 12
DO - Repubblica Dominicana 11
HN - Honduras 11
BO - Bolivia 10
KZ - Kazakistan 10
NP - Nepal 10
AZ - Azerbaigian 9
KW - Kuwait 9
PS - Palestinian Territory 9
TW - Taiwan 9
AL - Albania 8
CZ - Repubblica Ceca 8
CH - Svizzera 7
GT - Guatemala 7
JM - Giamaica 7
BB - Barbados 6
BH - Bahrain 6
BY - Bielorussia 6
CI - Costa d'Avorio 6
ET - Etiopia 6
SY - Repubblica araba siriana 6
CY - Cipro 5
GG - Guernsey 5
HR - Croazia 5
HU - Ungheria 5
LV - Lettonia 5
NI - Nicaragua 5
NO - Norvegia 5
PA - Panama 5
RS - Serbia 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
YE - Yemen 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
CR - Costa Rica 4
GE - Georgia 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
SV - El Salvador 4
AM - Armenia 3
DK - Danimarca 3
KG - Kirghizistan 3
Totale 30.048
Salva come PNG Salva come JPEG
Città #
Dallas 1.611
Singapore 1.502
Hong Kong 1.450
Moscow 1.322
Ashburn 786
San Jose 656
Shanghai 594
Hefei 512
Lawrence 457
Princeton 457
Lauterbourg 440
Ho Chi Minh City 416
Beijing 322
New York 257
Milan 211
São Paulo 210
Hanoi 196
Nuremberg 147
Los Angeles 133
Helsinki 122
Dublin 100
Rio de Janeiro 96
Santa Clara 86
Munich 79
Boardman 75
Tokyo 68
Orem 64
Belo Horizonte 56
Vienna 56
Chennai 52
Biên Hòa 50
Warsaw 50
Rome 47
London 46
Brooklyn 44
Montreal 43
Brasília 41
Denver 40
Guangzhou 39
Guayaquil 39
Poplar 39
Haiphong 38
Turku 38
Curitiba 37
Da Nang 36
Johannesburg 36
Frankfurt am Main 35
Houston 35
Quito 34
Stockholm 34
Porto Alegre 33
The Dalles 33
Atlanta 32
Mexico City 31
Phoenix 31
Campinas 28
Chicago 28
Council Bluffs 28
Salvador 28
Tianjin 28
Toronto 28
Boston 27
Baghdad 26
Asunción 24
Mumbai 24
Nairobi 24
Seattle 24
Sorocaba 24
Dhaka 23
Jakarta 23
Manchester 23
Tashkent 23
Goiânia 22
Hangzhou 22
Shenzhen 22
Washington 22
Hải Dương 21
Osasco 21
Pune 21
Cesano Boscone 20
Columbus 20
San Francisco 20
Ankara 19
Juiz de Fora 19
Ninh Bình 19
Thái Bình 19
Leicester 18
Amsterdam 17
Buenos Aires 17
Guarulhos 17
Querétaro 17
Santiago 17
Thái Nguyên 17
Bologna 16
Joinville 16
Lappeenranta 16
Manaus 16
Naples 16
Ribeirão Preto 15
Contagem 14
Totale 14.443
Salva come PNG Salva come JPEG
Nome #
Definition, diagnosis, and management of intravascular large B-Cell lymphoma: Proposals and perspectives from an international consensus meeting 318
Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma 245
3D-culture of CLL cells in bioreactor identifies the bone marrow as a key regulator of HS1 function in response to Ibrutinib 205
[Clinical value of spleen autograft]. FT Considerazioni sul valore clinico dell'autoinnesto di milza 187
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 185
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 161
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 146
A multicenter study of treatment of primary CNS lymphoma 143
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression 142
BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome 141
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 140
3D co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents 138
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 135
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias 134
THREE-HOUR INFUSION OF METHOTREXATE AT 3 g/m2 SIGNIFICANTLY REDUCES CNS RELAPSES AND IMPROVES SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS AND INCREASED CNS RISK 134
CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF HIGH-GRADE B-CELL LYMPHOMAS TRANSFORMED FROM INDOLENT LYMPHOMAS IN HIV-NEGATIVE AND HIV-POSITIVE PATIENTS 133
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 129
A MULTICENTER TRIAL ASSESSING FEASIBILITY AND EFFICACY OF A COMBINATION OF HIGH-DOSE METHOTREXATE, CYTARABINE AND THIOTEPA IN PATIENTS WITH PRIMARY CNS LYMPHOMA: IMPACT ON OUTCOME OF CYTARABINE DOSE 129
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial 126
A PHASE II STUDY TO INVESTIGATE THE PREVALENCE OF INFECTIOUS AGENTS IN OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL) AND THE EFFICACY OF ANTIBIOTIC THERAPY (IELSG#27 TRIAL) 126
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 123
A novel Rag2(-/-)gamma(-/-)(c)-xenograft model of human CLL 122
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL 121
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage 121
Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency 117
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 116
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 112
A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals 112
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.) 112
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 110
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 110
A screening study of Chlamydia psittaci infection in 172 cases of nodal and extranodal non-hodgkin lymphomas 109
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 108
A Six-Month Regimen of Oral Clarithromycin Is a Feasible and Active Therapy for Patients with Relapsed/Refractory Marginal Zone B-Cell Lymphoma of MALT-Type 107
SHORT-TERM DOSE-DENSE “CARMEN” THERAPY IS BETTER TOLERATED AND EVENLY EFFECTIVE THAN OTHER INTENSIFIED REGIMENS IN HIV- AND HIV+ PATIENTS WITH BURKITT LYMHOMA 106
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 105
Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models 103
A woman and her canary: a tale of chlamydiae and lymphomas 102
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 102
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models 101
Bone marrow as an alternative site for islet transplantation 100
A PHASE II TRIAL TO INVESTIGATE THE LINK WITH INFECTIOUS AGENTS IN OCULAR ADNEXAL MARGINAL ZONE LYMPHOMA, ESPECIALLY WITH CHLAMYDIA SPECIES, AND THE ANTINEOPLASTIC EFFECTS OF DOXYCYCLINE (IELSG#27) 100
Anti-CD20 monoclonal antibody (Rituximab) in gastric extranodal marginal zone (MALT) non-Hodgkin's lymphoma (NHL) patients: Clinical and biological results (Phase II study). 100
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 99
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia 97
DNA methylation alterations in prostate cancer: from diagnosis to treatment 96
Aggressive B-cell lymphoma with MYC/TP53 dual alterations displays distinct clinicopathobiological features and response to novel targeted agents 96
Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment 96
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 96
ORBIT IRRADIATION AS SALVAGE TREATMENT FOR PATIENTS WITH OCULAR ADNEXAL MALT LYMPHOMA (OAML) RELAPSED AFTER OR REFRACTORY TO CHLAMYDIA PSITTACI-ERADICATING ANTIBIOTIC THERAPY 94
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 94
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming 93
Activity of rituximab in extranodal marginal zone lymphomas (MALT-type). 92
Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects 91
Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells 91
A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma 90
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 90
CD4+T cells sustain aggressive chronic lymphocytic leukemia in Em- TCL1 mice through a CD40L-independent mechanism 90
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 89
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine 89
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial 89
Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura 88
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 88
In vitro models of the crosstalk between multiple myeloma and stromal cells recapitulate the mild NF-κB activation observed in vivo 87
In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor 87
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 87
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies 86
FEASIBILITY AND EFFICACY OF CHLAMYDIA PSITTACI ERADICATION WITH PROLONGED DOXYCYCLINE THERAPY IN LOCALIZED OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL): 7-YEAR RESULTS OF THE IELSG39 MULTICENTER TRIAL 86
The impact of histopathologic diagnosis on the proper management of testis neoplasms 86
Chlamydia infection and lymphoma: Multiple detection methods highlight an association beyond lymphomas of the ocular adnexa 86
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 86
Erratum: Autologous pancreatic islet transplantation in human bone marrow (Diabetes (2013) 62 (3523-3531)) 85
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation 85
Bone Marrow Histopathology in the Diagnostic Evaluation of Splenic Marginal-zone and Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Reliable Substitute for Spleen Histopathology? 85
Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis 85
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 85
Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center 85
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia 85
Salvage Irradiation for Ocular Adnexal Mucosa Associated Lymphoid Tissue Lymphoma Refractory to Chlamydia psittaci Eradication 84
Kikuchi-Fujimoto Disease Shows Frequent T-Cell Antigen Loss and MUM1 Expression in Cytotoxic T Cells: a Multi-institutional Italian Study 83
Atypical presentation of Churg-Strauss syndrome or an undescribed hypereosinophilic disease? 83
Autologous Pancreatic Islet Transplantation in Human Bone Marrow 83
Plasma cells require autophagy for sustainable immunoglobulin production 83
Accelerated progression to AIDS in macaques coinfected with simian immunodeficiency virus and human herpesvirus 6A 83
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 82
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination 81
Modeling Multiple Myeloma-Bone Marrow interactions and response to drugs in a 3D surrogate microenvironment 81
Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma 81
Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphoma 79
Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma 79
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation 79
Primary central nervous system lymphoma 79
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas 78
Central nervous system marginal zone B-cell lymphoma associated with chlamydophila psittaci infection 77
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 77
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes 77
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial 76
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival 75
Cyclin D3 immunoreactivity (IR) is an independent predictor of survival and drives the correct assessment of p27(KIP1) IR prognostic role in primary gastric lymphomas (PGL). 75
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial 74
Totale 10.599
Salva come PNG Salva come JPEG
Categoria #
all - tutte 194.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 194.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 1 0 0
2021/2022303 0 0 2 146 11 12 26 41 10 15 7 33
2022/20232.400 1.054 461 121 10 21 278 117 164 90 27 22 35
2023/20241.220 70 66 97 129 118 223 63 92 32 57 67 206
2024/20256.419 796 102 90 181 169 500 737 513 1.234 1.092 485 520
2025/202619.966 1.425 1.979 2.109 3.201 1.288 548 1.666 1.464 5.516 770 0 0
Totale 30.472